Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-22

Clinical Trial Update: Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers

View source ↗

Summary

A completed clinical trial update examining the roles of myostatin, activin A, and follistatin in cachexia associated with head and neck cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Cachexia, Squamous Cell Carcinoma | Status: COMPLETED